赭曲霉的高密度培养对坎利酮转化的影响

目的:研究赭曲霉高密度培养的发酵培养基及条件,实现坎利酮的高转化.方法:选取廉价易得的培养基成分并进行优化,同时对发酵条件进行优化,得到了最优发酵培养基配方及培养条件.结果:发酵培养基最优配方为:葡萄糖20g/L,玉米浆20g/L,酵母膏20g/L,K2HPO4 2.5g/L.种子液最佳培养时间为24h,发酵培养基初始pH 5.8,接种量为8%,装液量200mL/1000mL,摇床转速为180 r/min,28℃,底物投料时间24h,发酵结束时间72 h.结论:将该工艺在7L发酵罐中放大,菌体密度达到25.36g/L,11α羟基坎利酮的转化率为86.1%.     

桑黄液体发酵工艺的研究

通过对桑黄液体发酵培养基、培养条件优化实验研究,以获得具有与桑黄子实体相似功效成分的桑黄菌丝体液体发酵工艺。以菌丝体收率为主要考察指标,采用单因子及L9(34)正交实验的方法,对桑黄液体发酵培养基及培养条件进行优化,确定桑黄液体发酵工艺条件。桑黄液体发酵最佳培养基及培养条件:玉米粉2%,葡萄糖3%,酵母膏0.5%,蛋白胨0.5%,KH2PO40.3%,Mg SO4·7H2O 0.15%,VB120μg/100 m L,p H5.5,接种量8%,培养温度28℃,摇床转数180 r/min,培养周期82 h。优化条件下所获得桑黄菌丝体粉为土黄色,菌丝体平均得率为1.67%,菌丝体黄酮含量(0.84%)与桑黄子实体(0.88%)相当,菌丝体多糖含量(5.15%)是子实体(1.71%)的3倍。可见,该桑黄液体发酵工艺具有较大的推广应用价值。     

大菱鲆鳗弧菌灭活疫苗原液发酵条件的优化

为实现大菱鲆鳗弧菌灭活疫苗中试生产,通过对大菱鲆鳗弧菌菌株VAM003二级种子培养时间、盐度、培养基、接种量、补料等发酵条件的优化筛选,确定大菱鲆鳗弧菌菌株VAM003灭活疫苗发酵原液的发酵工艺条件。鳗弧菌菌珠VAM003接种于含2. 5%Na Cl的TSB液体发酵培养基,28℃振荡培养12～14 h,制备二级种子液,按发酵罐培养基总量的10%接种二级种子液,28℃补料发酵10～12 h。在该条件下鳗弧菌菌株VAM003发酵活菌数达到1. 20×1010cfu/m L,比优化前提高120%以上。     

甲壳素脱乙酰酶产生菌产酶条件的优化

采用斜面培养和液体发酵培养产甲壳素脱乙酰酶的真菌构巢曲霉,并且研究了产酶条件。结果表明,构巢曲霉的最适产酶条件为：发酵培养基初始pH值为6.5、发酵时间为96h、培养温度为31℃、碳源浓度为2%、氮源浓度为2%、金属离子浓度为0.01mol/L、接种量为6%。     

泥炭固体发酵生产单细胞蛋白研究

对以泥炭为唯一碳源,固体发酵生产单细胞蛋白(SCP)进行了一系列的研究。选用酵母菌和黑曲霉进行混合发酵培养,考察影响单细胞蛋白生产的各个因素,如菌种接种量,培养基含水量,发酵时间,发酵温度,培养基外加氮源等。通过正交实验设计确定了优化的培养条件。即:菌种接种量为10%,培养基含水量为300%,28℃培养72 h,以蛋白胨为氮源。     

黄霉素产生菌BBG1213的发酵工艺优化

对黄霉素产生菌Streptomyces bambergiensis1213培养基配方、种子培养时间及摇瓶装液量等培养条件进行优化,结果表明:当发酵培养基配方为:玉米淀粉3.5%、玉米浆0.6%、酵母粉1.0%、蛋白胨0.3%、黄豆饼粉2.5%、(NH4)2SO40.13%、K2HPO40.03%,BBG1213产抗水平最高;种子培养时间36h为宜;摇瓶装液量30ml,发酵周期86h-89h最佳。采用双碟法,建立了发酵液中黄霉素含量测定方法。     

β-葡聚糖酶高产菌株BS9418F的选育及其发酵条件的研究

经60 Coγ射线辐照处理获得的诱变菌株芽孢杆菌BS9418F ,其产酶活力比出发菌株提高 30 %以上。该菌株以大麦粉 7%、玉米粉 3%、豆粕 3%及适量无机盐为培养基最佳配比 ,其最适培养条件为 :培养基初始 pH 7.0 ,摇瓶装量 5 0mL/ 30 0mL三角瓶 ,种龄 16～ 2 0h ,接种量 2 %～ 3% ,培养温度 36～ 37℃ ,发酵周期 40h。在优化条件下 ,摇瓶发酵产 β 葡聚糖酶活力高达 5 5 0 0u/mL以上 ,比出发菌株初始发酵水平提高了 4倍以上     

重组大肠杆菌产尿素酶B高密度发酵条件的优化

探究重组大肠杆菌产尿素酶B（urease B subunit, UreB）的高密度发酵条件。通过实验室摇瓶和30 L发酵罐对UreB基因工程菌的发酵条件进行优化。结果表明：30 L发酵罐中以TB培养基为发酵培养基,接种量为5%,发酵温度为37 ℃,pH为6.8,溶氧量为30%左右,培养至2 h开始恒速流加50%甘油,4 h流加50%酵母提取物和50%胰蛋白胨,并加入终浓度为0.5 mmol/L的异丙基β-D-硫代半乳糖苷（isopropyl β-D-thiogalactoside,IPTG),诱导表达4 h,结束发酵,所得菌体干物质约为25.7 g/L,UreB表达量为31.4%。此工艺可以提高UreB的产量。     

一株猪源拟杆菌的分离与发酵条件的优化

从新鲜猪粪便中分离得到一株猪源拟杆菌,利用统计学的单因素试验与正交试验,对该菌株的发酵培养基及发酵条件进行优化。实验结果表明该菌发酵最适培养基为AN培养基,确定了促生长因子吐温-80、1%氯化血红素、1%维生素Kl的最佳浓度,并确定了最佳发酵条件,最佳培养温度为37℃、分批发酵时间周期18 h。     

绿色木霉在啤酒糟基质上产纤维素酶条件的优化

对绿色木霉接种到啤酒糟固态发酵产纤维素酶的培养基和培养条件进行优化,考察发酵物料起始含水量、发酵时间、起始pH值等发酵条件,以及啤酒糟培养基中添加麸皮、氮源种类对产酶的影响。结果表明,以啤酒糟为发酵基质接种绿色木霉生产纤维素酶是可行的。经单因素和正交试验获得最适固态发酵的培养条件为:起始pH 5~6,培养温度28~30℃,发酵4 d;最佳发酵培养基组合为:麸皮比例30%,培养基起始含水量50%,(NH₄)₂SO₄添加量为2.0%~2.5%。     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).